For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com

Global Immunotherapy Drugs Market valued approximately USD 108.5 billion in 2016 is anticipated to grow with a healthy growth rate of more than 14.0% over the forecast period 2017-2025. Faster drug approval processes, rising prevalence of lifestyle-oriented diseases, and rising adoption of targeted therapies are the primary growth drivers for global immunotherapy drugs market. However, the market growth is restricted by the high cost of immunotherapy treatment.

Global Immunotherapy market is segmented by type of drugs, therapy area, and end-use. Based on therapy area the market is segmented into cancer, autoimmune & inflammatory diseases, infectious diseases, and others. Among these, currently, the market is dominated by cancer segment which is anticipated to account for 33% revenue share in 2016. The cancer segment will continue to dominate over the forecast period and is also anticipated to register the highest growth over the forecast period. Increasing prevalence of cancer and rising adoption of immunotherapy for cancer treatment is driving the market growth.

Global Immunotherapy Drugs MarketThe objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type of Drugs:

  • Monoclonal Antibodies
  • Adult Vaccines
    • Preventive Vaccines
    • Therapeutic Vaccines
  • Checkpoint Inhibitors
  • Interferons Alpha & Beta
  • Interleukins
  • Other Drugs

By Therapy Area:

  • Cancer
  • Autoimmune & Inflammatory Diseases
  • Infectious Diseases
  • Other Therapy Area

By End-Use:

  • Hospitals
  • Clinics
  • Other End Users

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015

Base year – 2016

Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market F. Hoffmann, Merck & Co., Inc., Novartis International AG, Johnson & Johnson (A Parent Company of Jannssen Biotech, Inc.), GlaxoSmithKline PLC, Amgen Inc., Abbvie, Amstrazeneca, Bristol-Mysers Squibb, ELI Lilly & Company Frequent cross-industry partnerships are leading to market consolidation.

Target Audience of the Global Immunotherapy Drugs Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Chapter 1.      Global Immunotherapy Drugs Market Definition and Scope

1.1.      Research Objective

1.2.      Market Definition

1.3.      Scope of The Study

1.4.      Years Considered for The Study

1.5.      Currency Conversion Rates

1.6.      Report Limitation

Chapter 2.      Research Methodology

2.1.      Research Process

2.1.1.   Data Mining

2.1.2.   Analysis

2.1.3.   Market Estimation

2.1.4.   Validation

2.1.5.   Publishing

2.2.      Research Assumption

Chapter 3.      Executive Summary

3.1.      Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)

3.2.      Key Trends

Chapter 4.      Global Immunotherapy Drugs Market Dynamics

4.1.      Growth Prospects

4.1.1.   Drivers

4.1.2.   Restraints

4.1.3.   Opportunities

4.2.      Industry Analysis

4.2.1.   Porter’s 5 Force Model

4.2.2.   PEST Analysis

4.2.3.   Value Chain Analysis

4.3.      Analyst Recommendation & Conclusion

Chapter 5.      Global Immunotherapy Drugs Market, by Type of Drug

5.1.      Market Snapshot

5.2.      Market Performance – Potential Model

5.3.      Global Immunotherapy Drugs Market, Sub Segment Analysis

5.3.1.   Monoclonal Antibodies

5.3.1.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.1.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.   Adult Vaccines 

5.3.2.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.2.3.            Adult Vaccines Devices Sub-Segment estimate & forecasts, 2015-2025 (USD Billion)

5.3.2.3.1.         Preventive Vaccines

5.3.2.3.2.         Therapeutic Vaccines

5.3.3.   Checkpoint Inhibitors

5.3.3.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.3.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

 5.3.4.   Interferons Alpha & Beta

5.3.4.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.4.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.5.   Interleukins

5.3.5.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.5.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

5.3.6.   Others Drugs

5.3.6.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

5.3.6.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

 Chapter 6.      Global Immunotherapy Drugs Market, by Therapy Area

6.1.      Market Snapshot

6.2.      Market Performance – Potential Model

6.3.      Global Immunotherapy Drugs Market, Sub Segment Analysis

6.3.1.   Cancer

6.3.1.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.1.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.   Autoimmune & Inflammatory Diseases

6.3.2.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.2.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.   Infectious Diseases

6.3.3.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.3.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.   Other Therapy Areas

6.3.4.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

6.3.4.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

 Chapter 7.      Global Immunotherapy Drugs Market, by End-Use

7.1.      Market Snapshot

7.2.      Market Performance – Potential Model

7.3.      Global Immunotherapy Drugs Market, Sub Segment Analysis

7.3.1.   Hospital

7.3.1.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.1.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.   Clinics

7.3.2.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.2.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.   Other End User

7.3.3.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

7.3.3.2.            Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

 Chapter 8.      Global Immunotherapy Drugs Market, by Regional Analysis

8.1.      Immunotherapy Drugs Market, Regional Market Snapshot (2015-2025)

8.2.      North America Immunotherapy Drugs Market Snapshot

8.2.1.   U.S.

8.2.1.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.1.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.   Canada

8.2.2.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.2.2.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.      Europe Immunotherapy Drugs Market Snapshot

8.3.1.   U.K.

8.3.1.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.1.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.   Germany

8.3.2.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.   France

8.3.3.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.3.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.   Rest of Europe

8.3.4.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.4.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.      Asia Immunotherapy Drugs Market Snapshot

8.4.1.   China

8.4.1.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.1.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.   India

8.4.2.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.2.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.   Japan

8.4.3.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.3.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.   Rest of Asia Pacific

8.4.4.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.4.4.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.      Latin America Immunotherapy Drugs Market Snapshot

8.5.1.   Brazil

8.5.1.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.1.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.   Mexico

8.5.2.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.      Rest of The World

8.6.1.   South America

8.6.1.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.1.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.   Middle East and Africa

8.6.2.1.            Market estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.2.            Type of Drugs breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.3.            Therapy Area breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.6.2.4.            End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9.      Competitive Intelligence

9.1.      Company Market Share (Subject to Data Availability)

9.2.      Top Market Strategies

9.3.      Company Profilesa

9.3.1.   F.Hoffmann-LA Roche AG

9.3.1.1.            Overview

9.3.1.2.            Financial (Subject to Data Availability)

9.3.1.3.            Product Summary

9.3.1.4.            Recent Developments

9.3.2.   Merck & Co., Inc.

9.3.3.   Novartis International AG

9.3.4.   Johnson & Johnson (A Parent Company of Jannssen Biotech, Inc.)

9.3.5.   GlaxoSmithKline PLC

9.3.6.   Amgen Inc.

9.3.7.   Abbvie

9.3.8.   Astrazeneca

9.3.9.   Bristol-Mysers Squibb

9.3.10. ELI Lilly & Company

 

 

 

 

The research for Global Immunotherapy Drugs Market focuses deeply on the entire value chain of the market. However, the market size estimates are purely based on the consumer side of the value chain wherein the market sizes have been calculated by analyzing the average demand across various end-use such as hospitals, clinics and others.

The revenue for Global Immunotherapy Drugs Market is calculated as sum market sizes of different segments such as end-use and regions. The market revenue is calculated by bottom up approach, thereby summing up the revenues from various therapy areas. Further, some other key data points considered to calculate the revenue for Global Immunotherapy Drugs Market include:

  • Revenues from key companies
  • Key company market share analysis
  • Consumer spending analysis
  • Sales revenue generated by various end-use in different geographies

An extensive primary and secondary research has been conducted on key industry people, through questionnaires, telephonic conversations, email conversations, and interviews to verify the market estimations. Various government websites/portals and paid data sources are considered as a key source of secondary research.

We utilize a combination of bottom-up & top-down methodology for market estimations & forecasts. Additionally, we employ data triangulation techniques to verify each of the market estimates and forecasts through primary interviews and feedbacks.

All the estimates are derived from simulation models which is our proprietary technique. Each of these models is different from each other are a combination of correlation, regression and time series analysis. Each of these models is basically divided into two types namely economic and technological. Economical models are used to determine short-term market estimates and technological models are used for long-term estimates & forecasts. 


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.

Buy Now


Single User – $3,950

Enterprise License – $5,550

Loading…